• 1. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Introduction to 6-chloro-N-methylpyridin-3-amine (CAS No: 120739-84-6)

6-chloro-N-methylpyridin-3-amine, identified by its Chemical Abstracts Service (CAS) number 120739-84-6, is a significant compound in the realm of pharmaceutical and chemical research. This heterocyclic amine derivative features a pyridine core substituted with a chlorine atom at the 6-position and a methyl group at the 3-position, making it a versatile intermediate in synthetic chemistry. The unique structural attributes of this molecule contribute to its utility in the development of various bioactive agents, particularly in medicinal chemistry.

The synthesis of 6-chloro-N-methylpyridin-3-amine typically involves multi-step organic reactions, often starting from commercially available pyridine precursors. The introduction of the chloro substituent and the N-methyl group requires precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions or nucleophilic aromatic substitutions, have been employed to enhance the efficiency of these transformations. These techniques not only improve the overall yield but also minimize unwanted byproducts, making the process more sustainable and scalable for industrial applications.

In recent years, 6-chloro-N-methylpyridin-3-amine has garnered attention for its role as a key intermediate in the synthesis of pharmacologically active compounds. Its pyridine scaffold is a common motif in many drugs due to its ability to interact with biological targets through hydrogen bonding and hydrophobic interactions. The presence of both electron-withdrawing (chloro) and electron-donating (methyl) groups allows for further functionalization, enabling the creation of diverse molecular architectures.

One of the most compelling applications of 6-chloro-N-methylpyridin-3-amine is in the development of kinase inhibitors, which are critical in treating cancers and inflammatory diseases. Kinases are enzymes that play a pivotal role in cell signaling pathways, and their dysregulation is often associated with pathological conditions. By designing molecules that selectively inhibit specific kinases, researchers can develop targeted therapies with improved efficacy and reduced side effects. The structural flexibility of 6-chloro-N-methylpyridin-3-amine makes it an ideal candidate for scaffold hopping—a strategy used to explore new chemical space during drug discovery.

Recent studies have highlighted the potential of 6-chloro-N-methylpyridin-3-amine in the development of antiviral agents. The ability of viruses to rapidly mutate poses a significant challenge in drug design, necessitating compounds that can target conserved viral proteins. Researchers have leveraged the amine functionality of this compound to develop inhibitors that disrupt viral replication cycles. For instance, derivatives of 6-chloro-N-methylpyridin-3-amine have been shown to interfere with viral protease activity, thereby preventing the assembly of new viral particles. These findings underscore the importance of this compound in addressing emerging infectious diseases.

The pharmaceutical industry has also explored 6-chloro-N-methylpyridin-3-amine as a precursor for central nervous system (CNS) drugs. The blood-brain barrier (BBB) presents a formidable challenge for drug delivery, but compounds with appropriate lipophilicity and solubility can cross this barrier effectively. Modifications to the pyridine core, such as introducing fluorine atoms or altering the substitution pattern, can enhance BBB penetration. Preliminary studies suggest that certain derivatives of 6-chloro-N-methylpyridin-3-amine exhibit promising properties for treating neurodegenerative disorders like Alzheimer's disease and Parkinson's disease.

From an industrial perspective, the demand for high-quality intermediates like 6-chloro-N-methylpyridin-3-amine continues to grow as pharmaceutical companies seek innovative solutions for drug development. Manufacturers must adhere to stringent quality control measures to ensure consistency and reliability across batches. Advances in process optimization and green chemistry principles have enabled more efficient production methods, reducing waste and energy consumption without compromising purity.

The role of computational chemistry in designing derivatives of 6-chloro-N-methylpyridin-3-amine cannot be overstated. Molecular modeling techniques allow researchers to predict the binding affinity and pharmacokinetic properties of candidate compounds before synthesizing them in the lab. This approach accelerates drug discovery pipelines by identifying promising candidates early in the process. Additionally, artificial intelligence (AI)-based platforms are being increasingly utilized to screen large libraries of compounds for potential therapeutic applications.

In conclusion, 6-chloro-N-methylpyridin-3-amine (CAS No: 120739-84-6) is a multifaceted compound with significant implications in pharmaceutical research and drug development. Its unique structural features make it a valuable intermediate for synthesizing bioactive molecules targeting various diseases. As research continues to uncover new therapeutic applications, this compound is poised to remain at the forefront of medicinal chemistry innovation.

• 63756-61-6(3-Pyridinamine, 2-chloro-N-ethyl-)
• 793675-14-6(2-chloro-N-phenylpyridin-3-amine)
• 1374652-28-4(1-Chloro-N-methylisoquinolin-7-amine)
• 1374652-64-8(3-Chloro-N-methylisoquinolin-6-amine)
• 40932-43-2(2-Chloro-N-methylpyridin-3-amine)
• 5350-93-6(6-chloropyridin-3-amine)
• 142670-86-8(3-(N-Methylamino)-2,6-dichloropyridine)
• 206006-29-3(N-(6-chloro-3-pyridinyl)-Formamide)
• 41288-91-9(6-chloro-N,N-dimethyl-pyridin-3-amine)
• 944906-99-4(2-chloro-N-methylpyridin-4-amine)